JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 13, 2004; DOI: 10.1124/jpet.103.061242


0022-3565/04/3091-173-181$20.00
JPET 309:173-181, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.061242v1
309/1/173    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jutkiewicz, E. M.
Right arrow Articles by Woods, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jutkiewicz, E. M.
Right arrow Articles by Woods, J. H.

BEHAVIORAL PHARMACOLOGY

{delta}-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats

Emily M. Jutkiewicz, Erik B. Eller, John E. Folk, Kenner C. Rice, John R. Traynor, and James H. Woods

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (E.M.J., E.B.E., J.R.T., J.H.W.); and Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (J.E.F., K.C.R.)

The diarylpiperazine {delta}-opioid agonist SNC80 [(+)-4-[({alpha}R)-{alpha}-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide] produces convulsions, antidepressant-like effects, and locomotor stimulation in rats. The present study compared the behavioral effects in Sprague-Dawley rats of SNC80 with its two derivatives, SNC86 [(+)-4-[{alpha}(R)-{alpha}-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-hydroxyphenyl)methyl]-N,N-diethylbenzamide] and SNC162 [(+)-4-[({alpha}R)-{alpha}-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-phenyl)methyl]-N,N-diethylbenzamide], which differ by one functional group located in the 3-position of the benzylic ring. In behavioral measures, these three compounds demonstrated a rank order of potency and efficacy; SNC86 was the most potent and efficacious followed by SNC80 and then SNC162. In vitro, these compounds stimulated guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTP{gamma}S) binding in the caudate putamen of coronal brain slices from drug-naive rats as measured by in vitro autoradiography. In [35S]GTP{gamma}S binding studies, SNC86 seemed to be a full agonist at the {delta}-opioid receptor; however, SNC162 demonstrated reduced stimulation compared with SNC86, consistent with partial agonist activity. Although SNC80 was not fully efficacious in [35S]GTP{gamma}S autoradiography studies, it produced behavioral effects similar to those observed with SNC86, suggesting that the behavioral effects of SNC80 may be produced by its 3-hydroxy metabolite.


Received October 8, 2003; accepted December 11, 2003.

Address correspondence to: Dr. James H. Woods, 1301 MSRB 3, Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109-0632. E-mail: jhwoods{at}umich.edu




This article has been cited by other articles:


Home page
Mol. Interv.Home page
E. M. Jutkiewicz
The Antidepressant -like Effects of Delta-Opioid Receptor Agonists
Mol. Interv., June 1, 2006; 6(3): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Jutkiewicz, M. G. Baladi, J. E. Folk, K. C. Rice, and J. H. Woods
The Convulsive and Electroencephalographic Changes Produced by Nonpeptidic {delta}-Opioid Agonists in Rats: Comparison with Pentylenetetrazol
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1337 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Jutkiewicz, S. T. Kaminsky, K. C. Rice, J. R. Traynor, and J. H. Woods
Differential Behavioral Tolerance to the {delta}-Opioid Agonist SNC80 ([(+)-4-[({alpha}R)-{alpha}-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley Rats
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Jutkiewicz, N. P. Walker, J. E. Folk, K. C. Rice, P. S. Portoghese, J. H. Woods, and J. R. Traynor
Comparison of Peptidic and Nonpeptidic {delta}-Opioid Agonists on Guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTP{gamma}S) Binding in Brain Slices from Sprague-Dawley Rats
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1314 - 1320.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.